$278 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 64 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 22.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VRTX | Buy | Vertex Pharmaceuticals Inc | $20,444,000 | +43.6% | 93,422 | +11.2% | 7.36% | +12.0% |
| GILD | Sell | Gilead Sciences Inc | $19,055,000 | -4.9% | 293,284 | -7.3% | 6.86% | -25.9% |
| AMGN | Amgen Inc | $15,899,000 | +24.5% | 66,000 | 0.0% | 5.73% | -2.9% | |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $14,371,000 | +487.5% | 336,000 | +394.1% | 5.18% | +358.1% |
| NBIX | Sell | Neurocrine Biosciences Inc | $14,322,000 | +8.0% | 133,300 | -9.5% | 5.16% | -15.8% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB LTD | $14,114,000 | +137.7% | 390,000 | +78.9% | 5.08% | +85.3% |
| BIIB | Buy | Biogen Inc | $13,552,000 | +83.6% | 45,700 | +44.2% | 4.88% | +43.1% |
| REGN | Sell | Regeneron Pharmaceuticals | $10,825,000 | -2.0% | 28,830 | -27.6% | 3.90% | -23.6% |
| STML | Buy | Stemline Therapeutics Inc | $10,251,000 | +17.9% | 965,245 | +15.6% | 3.69% | -8.1% |
| ALXN | Sell | Alexion Pharmaceuticals Inc | $9,310,000 | -6.9% | 86,141 | -15.7% | 3.35% | -27.4% |
| BMRN | Buy | Biomarin Pharmaceutical Inc | $8,814,000 | +49.8% | 104,284 | +19.5% | 3.18% | +16.8% |
| ILMN | ILLUMINA INC | $8,323,000 | +9.0% | 25,100 | 0.0% | 3.00% | -15.0% | |
| AMRN | Buy | Amarin Corp Plcspons adr new | $8,315,000 | +111.8% | 388,000 | +49.8% | 3.00% | +65.1% |
| MRK | New | MERCK & CO INC | $7,546,000 | – | 83,000 | +100.0% | 2.72% | – |
| SGEN | Sell | Seattle Genetics Inc | $7,311,000 | +29.0% | 64,000 | -3.6% | 2.63% | +0.6% |
| INCY | Sell | Incyte Corp | $5,586,000 | -22.0% | 64,000 | -33.7% | 2.01% | -39.2% |
| PTCT | Sell | PTC Therapuetics COM | $5,470,000 | -31.5% | 114,000 | -51.7% | 1.97% | -46.6% |
| HALO | Buy | Halozyme Therapeutics Inc | $5,454,000 | +568.4% | 307,633 | +484.5% | 1.96% | +421.2% |
| SRPT | Buy | Sarepta Therapeutics Inc | $5,173,000 | +163.1% | 40,100 | +53.6% | 1.86% | +105.1% |
| ALNY | Buy | Alnylam Pharmaceuticals Inc | $4,987,000 | +83.7% | 43,300 | +28.1% | 1.80% | +43.2% |
| KALV | Buy | Kalvista Pharmaceuticals Inc | $4,924,000 | +139.3% | 277,433 | +56.4% | 1.77% | +86.5% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $4,630,000 | +445.3% | 35,900 | +229.4% | 1.67% | +325.5% |
| IONS | Buy | Ionis Pharmaceuticals Inc | $3,246,000 | +17.3% | 53,781 | +16.5% | 1.17% | -8.6% |
| NKTR | Buy | NEKTAR THERAPEUTICS | $3,021,000 | +176.4% | 140,000 | +133.3% | 1.09% | +115.4% |
| XLRN | Buy | ACCELERON PHARMA INC | $3,021,000 | +155.2% | 57,000 | +90.0% | 1.09% | +98.9% |
| NVCR | New | NOVOCURE LTD | $2,991,000 | – | 35,500 | +100.0% | 1.08% | – |
| SAGE | Buy | Sage Therapeutics Inc | $2,983,000 | +32.9% | 41,400 | +158.8% | 1.08% | +3.7% |
| SGMO | Sell | Sangamo Therapeutics Inc | $2,533,000 | -20.0% | 303,000 | -13.4% | 0.91% | -37.7% |
| BGNE | New | BEIGENE LTDsponsored adr | $2,321,000 | – | 14,000 | +100.0% | 0.84% | – |
| ZGNX | Buy | Zogenix Inc | $2,223,000 | +285.3% | 42,700 | +196.5% | 0.80% | +200.0% |
| MYOK | Myokardia INC | $2,186,000 | +39.8% | 30,000 | 0.0% | 0.79% | +8.9% | |
| TPTX | New | TURNING POINT THERAPEUTICS I | $2,179,000 | – | 35,000 | +100.0% | 0.78% | – |
| ASND | Ascendis Pharma ASsponsored adr | $1,918,000 | +44.3% | 13,800 | 0.0% | 0.69% | +12.5% | |
| GBT | Buy | Global Blood Therapeutics | $1,836,000 | +104.7% | 23,100 | +24.9% | 0.66% | +59.3% |
| EXEL | Exelixis Inc | $1,824,000 | -0.3% | 103,534 | 0.0% | 0.66% | -22.3% | |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $1,787,000 | – | 30,000 | +100.0% | 0.64% | – |
| AGIO | Agios Pharmaceuticals Inc | $1,743,000 | +47.7% | 36,500 | 0.0% | 0.63% | +15.2% | |
| MNTA | MOMENTA PHARMACEUTICALS INC | $1,575,000 | +52.0% | 80,000 | 0.0% | 0.57% | +18.4% | |
| STRO | SUTRO BIOPHARMA INC | $1,528,000 | +20.9% | 139,331 | 0.0% | 0.55% | -5.8% | |
| BLUE | Bluebird Bio Inc | $1,491,000 | -4.5% | 17,000 | 0.0% | 0.54% | -25.5% | |
| GMED | Globus Med Inc | $1,425,000 | +15.2% | 24,200 | 0.0% | 0.51% | -10.3% | |
| TCDA | Tricida Inc | $1,393,000 | +22.1% | 37,000 | 0.0% | 0.50% | -4.7% | |
| BPMC | Blueprint Medicines Corp | $1,362,000 | +9.0% | 17,000 | 0.0% | 0.49% | -15.1% | |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $1,340,000 | – | 22,000 | +100.0% | 0.48% | – |
| MLND | Millendo Therapeutics Inc | $1,191,000 | -5.8% | 177,825 | 0.0% | 0.43% | -26.5% | |
| GWPH | Sell | GW Pharmaceuticals Plcads | $1,066,000 | -53.2% | 10,200 | -48.5% | 0.38% | -63.5% |
| DCPH | DECIPHERA PHARMACEUTICALS INC | $1,057,000 | +83.2% | 17,000 | 0.0% | 0.38% | +42.7% | |
| EXAS | Exact Sciences Corp | $989,000 | +2.3% | 10,700 | 0.0% | 0.36% | -20.4% | |
| QURE | Sell | UNIQURE NV | $967,000 | -10.6% | 13,500 | -50.9% | 0.35% | -30.4% |
| FOLD | Buy | Amicus Therapeutics Inc | $920,000 | +95.7% | 94,600 | +61.4% | 0.33% | +52.5% |
| IFRX | New | INFLARX NV | $869,000 | – | 220,000 | +100.0% | 0.31% | – |
| FGEN | FibroGen Inc | $845,000 | +16.1% | 19,700 | 0.0% | 0.30% | -9.5% | |
| INSM | Sell | INSMED INC | $801,000 | -87.3% | 33,600 | -90.6% | 0.29% | -90.1% |
| ARNA | Arena Pharmaceuticals Inc | $749,000 | -0.8% | 16,500 | 0.0% | 0.27% | -22.6% | |
| MYGN | Myriad Genetics inc | $680,000 | -5.0% | 25,000 | 0.0% | 0.24% | -26.0% | |
| AKCA | AKCEA THERAPEUTICS INC | $536,000 | +9.8% | 31,723 | 0.0% | 0.19% | -14.6% | |
| SUPN | Supernus Pharmaceuticals Inc | $473,000 | -13.7% | 19,953 | 0.0% | 0.17% | -32.8% | |
| DERM | Dermira Inc | $454,000 | +137.7% | 30,000 | 0.0% | 0.16% | +86.4% | |
| MOR | New | MORPHOSYS AGsponsored ads | $402,000 | – | 11,295 | +100.0% | 0.14% | – |
| RDUS | Radius Health Inc | $342,000 | -21.7% | 17,000 | 0.0% | 0.12% | -39.1% | |
| GTHX | G1 Therapeutics Inc | $296,000 | +16.1% | 11,200 | 0.0% | 0.11% | -9.3% | |
| ZEAL | New | ZEALAND PHARMA A Ssponsored adr | $188,000 | – | 5,653 | +100.0% | 0.07% | – |
| ANAB | ANAPTYSBIO INC | $163,000 | -53.4% | 10,000 | 0.0% | 0.06% | -63.6% | |
| ARQL | Exit | Arqule INC | $0 | – | -41,000 | -100.0% | -0.14% | – |
| RGEN | Exit | REPLIGEN CORP | $0 | – | -24,000 | -100.0% | -0.85% | – |
| ABMD | Exit | Abiomed Inc | $0 | – | -11,700 | -100.0% | -0.96% | – |
| CELG | Exit | Celgene Corp | $0 | – | -171,022 | -100.0% | -7.85% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-18
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.